By Kamal Choudhury Jan 30 (Reuters) - Shares of Corcept Therapeutics fell 16% on Friday after a corrected "complete response ...

By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...

A follow-up study suggests that aspirin therapy does not reduce cancer risk in older adults, but may instead increase ...

Cullough of Wiley Rein LLP discuss the Department of Justice Criminal Division's Fraud Section year in review, including ...

Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could ...

Understood reports that artificial food dyes, like Red 40, may worsen ADHD symptoms in some children, prompting a phase-out ...

The FDA gave the recall the lowest risk level, Class III.

In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 ...

The target action date for orforglipron is now April 10.

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.

MEXICO CITY (AP) — When a drug cartel came calling at a store selling vapes in northern Mexico, the owners knew they were powerless. The cartel abducted two employees, blindfolded them and demanded to ...

ALLENTOWN - In a big win for Pennsylvania and the Lehigh Valley, Eli Lilly & Co. has announced plans to build a $3.5 billion drug production plant in Lehigh County. Gov. Josh Shapiro says Lilly’s ...